Current Drug Targets
Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Ranking and Category
-
131st of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Targets, Volume 8 - Number 3
Protein Kinases as Targets for Antiparasitic Chemotherapy Drugs
, 8(3): 389 - 398Fernanda Canduri, Patricia Cardoso Perez, Rafael A. Caceres and Walter F. de Azevedo
DOI: 10.2174/138945007780058979
Enoyl Reductases as Targets for the Development of Anti-Tubercular and Anti-Malarial Agents
, 8(3): 399 - 411J. S. Oliveira, I. B. Vasconcelos, I. S. Moreira, D. S. Santos and L. A. Basso
DOI: 10.2174/138945007780058942
Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases
, 8(3): 413 - 422R. G. Silva, J. E. S. Nunes, F. Canduri, J. C. Borges, L. M. Gava, F. B. Moreno, L. A. Basso and D. S. Santos
DOI: 10.2174/138945007780058997
Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design
, 8(3): 423 - 435R. G. Ducati, L. A. Basso and D. S. Santos
DOI: 10.2174/138945007780059004
Chorismate Synthase: An Attractive Target For Drug Development Against Orphan Diseases
, 8(3): 437 - 444Marcio V. B. Dias, Fernanda Ely, Mario S. Palma, Walter F. de Azevedo, Luiz A. Basso and Diogenes S. Santos
DOI: 10.2174/138945007780058924
The Inhibition of 5-enolpyruvylshikimate-3-phosphate Synthase as a Model for Development of Novel Antimicrobials
, 8(3): 445 - 457Mauricio Ribeiro Marques, Jose Henrique Pereira, Jaim S. Oliveira, Luiz Augusto Basso, Walter Filgueira de Azevedo, Diogenes Santiago Santos and Mario Sergio Palma
DOI: 10.2174/138945007780058951
Shikimate Kinase: A Potential Target for Development of Novel Antitubercular Agents
, 8(3): 459 - 468Jose H. Pereira, Igor B. Vasconcelos, Jaim S. Oliveira, Rafael A. Caceres, Walter F. de Azevedo, Luis A. Basso and Diogenes S. Santos
DOI: 10.2174/138945007780059013
Identifying and Attaining LDL-C Goals: Mission Accomplished? Next Target: New Therapeutic Options to Raise HDL-C Levels
, 8(3): 483 - 488Vasilios G. Athyros, Dimitri P. Mikhailidis, Anna I. Kakafika, Asterios Karagiannis, Apostolos Hatzitolios, Konstantinos Tziomalos, Emmanuel S. Ganotakis, Evangelos N. Liberopoulos and Moses Elisaf
DOI: 10.2174/138945007780058933
  |
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net